Would you sell a kidney in a regulated kidney market? Results of an exploratory study

Journal of Medical Ethics

Volumn 35, Issue 9, 2009, Pages 558-564

  Rid, A ^a,b   Bachmann, L M ^b   Wettstein, V ^b   Biller Andorno, N ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; COMMERCIAL PHENOMENA; DONOR; ECONOMICS; ETHICS; FEMALE; HOSPITAL ADMISSION; HUMAN; KIDNEY; LEGAL ASPECT; MALE; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; SWITZERLAND; TRANSPLANTATION;

ADULT; COMMERCE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KIDNEY; MALE; SOCIOECONOMIC FACTORS; SWITZERLAND; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS; YOUNG ADULT;

EID: 72449209712     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2008.026856     Document Type: Article

References (32)

1. Organ Procurement and Transplantation Network. Data reports. http.://optn.transplant.hrsa.gov/latestData/viewDataReports.asp (accessed 25 Jun 2009).
2. Shimazono Y. The state of the international organ trade: a provisional picture based on integration of available information. Bull World Health Organ 2007;85:955-62.
3. Erin CA, Harris J. A monopsonistic market: or how to buy and sell human organs, tissues and cells ethically. In: Robertson I, ed. Life and death under high technology medicine. Manchester: Manchester University Press, 1994:134-57.
4. Harris J, Erin C. An ethically defensible market in organs. BMJ 2002;325:114-5.
5. Erin CA, Harris J. An ethical market in human organs. J Med Ethics 2003;29:137-8.
6. Matas AJ. Should we pay donors to increase the supply of organs for transplantation? Yes. BMJ 2008;336:1342.
7. Hippen BE, Gaston RS. The conspicuous costs of more of the same. Am J Transplant 2006;6:1503-4.
8. Bryce CL, Siminoff LA, Ubel PA, et al. Do incentives matter? Providing benefits to families of organ donors. Am J Transplant 2005;5:2999-3008.
9. Jasper JD, Nickerson CA, Hershey JC, et al. The public's attitudes toward incentives for organ donation. Transplant Proc1999;31:2181-4.
10. Kittur DS, Hogan MM, Thukral VK, et al. Incentives for organ donation? The United Network for Organ Sharing ad hoc donations committee. Lancet 1991;338:1441-3.
11. Prottas JM. Buying human organs-evidence that money doesn't change everything. Transplantation 1992;53:1371-3.
12. Boulware LE, Troll MU, Wang NY, et al. Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. Am J Transplant 2006;6:2774-85.
13. Kranenburg L, Schram A, Zuidema W, et al. Public survey of financial incentives for kidney donation. Nephrol Dial Transplant 2008;23:1039-42.
14. Hippen BE. Organ sales and moral travails. lessons from the living kidney vendor program in Iran. Washington, DC: Cato Institute, 2008.
15. Matas AJ, Bartlett ST, Leichtman AB, et al. Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant 2003;3:830-4.
16. Schweizerisches Bundesamt für Statistik. Studien- und Lebensbedingungen an den Schweizer Hochschulen: Hauptbericht der Studie zur sozialen Lage der Studierenden 2005. Neuchâtel: Schweizerisches Bundesamt für Statistik, 2007.
17. European Observatory on Health Care Systems. Health care systems in transition: Switzerland. Copenhagen: European Observatory on Health Care Systems, 2000.
18. Swisstransplant. Annual report 2007. www.swisstransplant.ch/eng/More/Annual-reports/Annual-report-2007 (accessed 18 June 2009).
19. Kühberger A, Schulte-Mecklenbeck M, Perner J. Framing decisions: hypothetical and real. Organizational Behavior and Human Decision Processes 2002;89:1162-75.
20. Buchbinder SP, Metch B, Holte SE, et al. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 2004;36:604-12.
21. Kraus SJ. Attitudes and the prediction of behavior: a meta-analysis of the empirical literature. Pers Soc Psychol Bull 1995;21:58-75.
22. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000;320:1530-3.
23. Veatch RM. Why liberals should accept financial incentives for organ procurement. Kennedy Inst Ethics J 2003;13:19-36.
24. Matas AJ. The case for living kidney sales: rationale, objections and concerns. Am J Transplant 2004;4:2007-17.
25. Satel S. Supply, demand, and kidney transplants: a bad incentive structure createsa dire shortage. Policy Review 2007;144:59-69.
26. Hippen BE. In defense of a regulated market in kidneys from living vendors. J Med Philos 2005;30:593-626.
27. Mack S, Huggins V, Keathley D, et al. Do monetary incentives improve response rates in the survey of income and program participation? Proceedings of the Section on Survey Methodology, American Statistical Association 1998:529-34.
28. Almeida L, Azevedo B, Nunes T, et al. Why healthy subjects volunteer for phase I studies and how they perceive their participation? Eur J Clin Pharmacol 2007;63:1085-94.
29. Zargooshi J. Iranian kidney donors: motivations and relations with recipients. J Urol 2001;165:386-92.
30. Goyal M, Mehta RL, Schneiderman LJ, et al. Economic and health consequences of selling a kidney in India. JAMA 2002;288:1589-93.
31. Naqvi SA, Ali B, Mazhar F, et al. A socioeconomic survey of kidney vendors in Pakistan. Transpl Int 2007;20:934-9.
32. Matas AJ. Why we should develop a regulated system of kidney sales: a call for action! Clin J Am Soc Nephrol 2006;1:1129-32.